News Focus
News Focus
icon url

BIOChecker4

03/03/23 8:24 PM

#405739 RE: Phoenix64 #405738

The stock is being held down by a CEO who keeps shooting himself in the foot, keeps moving goal posts, misses self-imposed milestones, finances operations through a vulture investor, is a terrible communicator and has no credibility with biotech institutional investors.

Good science (though it still unproven to regulators) does not make up for weak management and a board of directors that protects management at the expense of shareholders.
icon url

bb8675309

03/03/23 9:56 PM

#405741 RE: Phoenix64 #405738

Agree. With the information we know today on all drug trial results this company should have a $5 to $10 billion market cap. Diagnosis! Market corruption. imo
icon url

ignatiusrielly35

03/03/23 10:08 PM

#405742 RE: Phoenix64 #405738

It’s got nothing to do with BPs trying to prevent competition. It’s simply market makers/hedge funds addicted to dealing from the short side and making trading profits. The Fraudstein trading cabal latched onto it and they don’t want to let go. Unless and until they are forced to do so. Pretty simple, really. Their agents are familiar to everyone here.
icon url

Bourbon_on_my_cornflakes

03/05/23 1:20 PM

#405888 RE: Phoenix64 #405738

This stock is being held down by various unscrupulous entities.

Bull. This stock is being held down by its inability to release clear and convincing data.